(NASDAQ: PSNL) Personalis's forecast annual revenue growth rate of 30.8% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.67%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.13%.
Personalis's revenue in 2026 is $69,669,000.On average, 9 Wall Street analysts forecast PSNL's revenue for 2026 to be $8,845,806,198, with the lowest PSNL revenue forecast at $8,195,181,378, and the highest PSNL revenue forecast at $9,599,172,495. On average, 9 Wall Street analysts forecast PSNL's revenue for 2027 to be $12,005,373,612, with the lowest PSNL revenue forecast at $10,602,450,493, and the highest PSNL revenue forecast at $13,244,252,127.
In 2028, PSNL is forecast to generate $17,095,455,511 in revenue, with the lowest revenue forecast at $15,228,593,748 and the highest revenue forecast at $18,929,209,313.